BHC (Bausch Health) Cyclically Adjusted Revenue per Share: $27.28 (As of Mar. 2026)


BHC Bausch Health Companies Inc BHC
58 GF Score
Price $4.90
GF Value $7.85
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Bausch Health Cyclically Adjusted Revenue per Share?

Bausch Health BHC +2.73% 58 Cyclically Adjusted Revenue per Share is $27.28 as of Mar. 2026. GuruFocus rates BHC with a GF Score™ of 58/100 and a GF Value™ of $7.85 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bausch Health's adjusted revenue per share for the three months ended in Mar. 2026 was $6.770. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $27.28 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Bausch Health's average Cyclically Adjusted Revenue Growth Rate was -1.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 6.10% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bausch Health was 24.90% per year. The lowest was 2.30% per year. And the median was 11.45% per year.

As of today (2026-07-04), Bausch Health's current stock price is $4.90. Bausch Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $27.28. Bausch Health's Cyclically Adjusted PS Ratio of today is 0.18.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bausch Health was 2.58. The lowest was 0.16. And the median was 0.91.


Bausch Health  (NYSE:BHC) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bausch Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=4.90/27.28
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bausch Health was 2.58. The lowest was 0.16. And the median was 0.91.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bausch Health Cyclically Adjusted Revenue per Share Related Terms


Bausch Health Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Bausch Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health Cyclically Adjusted Revenue per Share Chart

Bausch Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.01 26.00 28.10 26.41 27.49

Bausch Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.68 28.12 27.41 27.49 27.28

BHC vs ZTS, UTHR: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bausch Health's Cyclically Adjusted PS Ratio falls into.


BHC
58GF Score
Bausch Health Companies Inc BHC
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bausch Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bausch Health's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=6.77/132.2600*132.2600
=6.770

Current CPI (Mar. 2026) = 132.2600.

Bausch Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 7.014 102.002 9.095
201609 7.093 101.765 9.219
201612 6.872 101.449 8.959
201703 6.017 102.634 7.754
201706 6.378 103.029 8.188
201709 6.299 103.345 8.061
201712 6.127 103.345 7.841
201803 5.689 105.004 7.166
201806 6.058 105.557 7.591
201809 6.077 105.636 7.609
201812 6.027 105.399 7.563
201903 5.739 106.979 7.095
201906 6.112 107.690 7.506
201909 6.268 107.611 7.704
201912 6.306 107.769 7.739
202003 5.693 107.927 6.977
202006 4.683 108.401 5.714
202009 5.975 108.164 7.306
202012 6.218 108.559 7.576
202103 5.681 110.298 6.812
202106 5.859 111.720 6.936
202109 5.799 112.905 6.793
202112 6.098 113.774 7.089
202203 5.316 117.646 5.976
202206 5.431 120.806 5.946
202209 5.630 120.648 6.172
202212 6.048 120.964 6.613
202303 5.351 122.702 5.768
202306 5.903 124.203 6.286
202309 6.125 125.230 6.469
202312 6.577 125.072 6.955
202403 5.870 126.258 6.149
202406 6.491 127.522 6.732
202409 6.813 127.285 7.079
202412 6.937 127.364 7.204
202503 6.112 129.181 6.258
202506 6.781 129.892 6.905
202509 7.140 130.290 7.248
202512 7.403 130.370 7.510
202603 6.770 132.260 6.770

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $27.28 mean?
Bausch Health (BHC) has a Cyclically Adjusted Revenue per Share of $27.28 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bausch Health and its competitors.
Is Bausch Health's Cyclically Adjusted Revenue per Share too high?
Bausch Health's current Cyclically Adjusted Revenue per Share is $27.28. Overall, Bausch Health has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bausch Health's Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
Bausch Health's Cyclically Adjusted Revenue per Share of $27.28 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bausch Health and its competitors. Bausch Health's current Cyclically Adjusted Revenue per Share is $27.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch Health stock overvalued right now?
Based on GuruFocus' analysis, Bausch Health (BHC) is currently considered Possible Value Trap. The stock's GF Value™ is $7.85, compared to a current price of $4.90 — trading 37.6% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $27.28. Bausch Health's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Bausch Health (BHC), the current Cyclically Adjusted Revenue per Share is $27.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bausch Health (BHC) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of $4.90 is trading 37.6% below its estimated GF Value™ of $7.85. GuruFocus considers Bausch Health to be Possible Value Trap.

Key valuation signals for BHC:

  • Cyclically Adjusted Revenue per Share: $27.28
  • GF Value™: $7.85 vs. price of $4.90 (37.6% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the BHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
58GF Score

Get the complete analysis for BHC

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.90
Price
$7.85
GF Value